Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
315.45
549.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ADVENZYMES stock under the Base Case scenario is 268.61 INR. Compared to the current market price of 379.75 INR, Advanced Enzyme Technologies Ltd is Overvalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Advanced Enzyme Technologies Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ADVENZYMES cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Advanced Enzyme Technologies Ltd
Balance Sheet Decomposition
Advanced Enzyme Technologies Ltd
Current Assets | 8.1B |
Cash & Short-Term Investments | 5.5B |
Receivables | 989.4m |
Other Current Assets | 1.6B |
Non-Current Assets | 7.3B |
Long-Term Investments | 43.6m |
PP&E | 3.1B |
Intangibles | 3.8B |
Other Non-Current Assets | 305.2m |
Current Liabilities | 1.1B |
Accounts Payable | 157.6m |
Other Current Liabilities | 906m |
Non-Current Liabilities | 1B |
Long-Term Debt | 228.2m |
Other Non-Current Liabilities | 821.6m |
Earnings Waterfall
Advanced Enzyme Technologies Ltd
Revenue
|
6.3B
INR
|
Cost of Revenue
|
-1.4B
INR
|
Gross Profit
|
4.9B
INR
|
Operating Expenses
|
-3.1B
INR
|
Operating Income
|
1.8B
INR
|
Other Expenses
|
-377.4m
INR
|
Net Income
|
1.4B
INR
|
Free Cash Flow Analysis
Advanced Enzyme Technologies Ltd
INR | |
Free Cash Flow | INR |
ADVENZYMES Profitability Score
Profitability Due Diligence
Advanced Enzyme Technologies Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Advanced Enzyme Technologies Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
ADVENZYMES Solvency Score
Solvency Due Diligence
Advanced Enzyme Technologies Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Advanced Enzyme Technologies Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ADVENZYMES Price Targets Summary
Advanced Enzyme Technologies Ltd
According to Wall Street analysts, the average 1-year price target for ADVENZYMES is 408 INR with a low forecast of 404 INR and a high forecast of 420 INR.
Dividends
Current shareholder yield for ADVENZYMES is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Advanced Enzyme Technologies Ltd. engages in the research, development, manufacture, and sale of enzyme products. The company is headquartered in Thane, Maharashtra and currently employs 322 full-time employees. The company went IPO on 2016-08-01. The firm is focused on the research and development, manufacturing and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. The company provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing and malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. The company offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather and bio-fuels. Its oils and fats processing include oil extraction, oil refining fish oil processing, biodiesel and oleochemicals.
Contact
IPO
Employees
Officers
The intrinsic value of one ADVENZYMES stock under the Base Case scenario is 268.61 INR.
Compared to the current market price of 379.75 INR, Advanced Enzyme Technologies Ltd is Overvalued by 29%.